Page 11 - Health Sector

Aurobindo's Eugia recalls pain-relieving injection Methocarbamol in US

The recall comes after a consumer complained about possible contamination

Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines

Bilthoven Biologicals will produce the vaccines for distribution in India and worldwide

Govt mandates linking of CGHS and ABHA IDs to integrate health schemes

The CGHS scheme provides comprehensive healthcare services to central government employees, pensioners, and their dependent family members

CAR-T cell therapy raising hopes for cancer patients, medical tourism

CAR-T therapy is seen to be on the verge of a breakthrough, raising hopes for both cancer patients as well as medical tourism. But can it become the first line of treatment?

Aster DM's deal to separate India and GCC businesses nears completion

In November 2023, Aster DM had received corporate approvals to separate its India and Gulf Cooperation Council (GCC) businesses into two distinct and standalone entities

2K doctors from India to plug UK's national health service shortage

Doctors in India view this move as temporary, citing the high number of doctors produced in the country each year

Centre forms committee to look into Ayushman Bharat implementation

A key task of the committee is to suggest measures to prevent fraud or misuse of the scheme

Entod Pharmaceuticals develops human insulin eye drops to treat corneal eye

Recent research suggests that insulin eye drops can be effective in repairing corneal tissue and treating ocular surface conditions

Max Healthcare and Touch Healthcare signs agreement to settle dispute

Max Healthcare accused Touch Healthcare of favouring Blackstone's offer over a prior agreement for Care Hospitals' sale

A wiser world after Covid

Another pandemic or global scale disaster is inevitable but the Covid experience will help us deal with it better

Healthcare innovation to double at $60 bn opportunity by FY28 in India

Indian vaccines and biotech market, which was valued at $4 billion in FY23, accounting for 15 percent of the innovation market, has quickly grown from $1.2 billion in FY20

Double-blind trial soon for Ayush drugs to treat anaemia in women

The ministry on Monday tied up with the Indian Council of Medical Research (ICMR) to conduct the study, which aims at backing up Ayush treatment with scientific and evidence-based research

'Two-thirds of greenfield units under PLI for bulk drugs completed'

Union Minister of Chemical and Fertilisers Mansukh Mandaviya on Saturday inaugurated 40 greenfield facilities to manufacture bulk drugs and medical devices under the PLI scheme

Biocon Biologics gets green light to launch Yesafili biosimilar in Canada

Under the agreement, Biocon Biologics will launch Yesafili no later than July 1, 2025. Health Canada had granted tentative approval for Yesafili in March 2023

Major hospital chains report increase in average revenue per occupied bed

The increase in ARPOB comes despite significant bed additions by hospitals in the past two financial years

Pfizer, Niper collaborate to support healthcare startups in India

The Pfizer INDovation initiative, which has supported 34 startups in India till now, is now expanding its reach through this collaboration with NIPER Ahmedabad

Union min Baghel inaugurates 1st National Public Health India conference

He said that programs are also being run by the Health Ministry regarding the elimination of Kala-azar. Apart from this, the rural housing scheme also has an important contribution to this

Preventive and wellness tests drive growth for diagnostic companies

Covid-19 led to increase in self-testing awareness, particularly about preventive and wellness services

Understanding Dermatomyositis, the disease that claimed Dangal star's life

Often misunderstood due to its rarity and complex symptoms, this condition requires comprehensive understanding and awareness to ensure timely diagnosis and effective management

GPT Healthcare sets price band at Rs 177-188 for IPO opening on Feb 22

The company revealed the price band for its upcoming initial public offering (IPO), set at Rs 177 to 188 per share